Testing effectiveness (Phase 2)Ended earlyNCT01561430
What this trial is testing
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 70